Affinia Therapeutics is a gene therapy company dedicated to expanding the potential of gene therapies for common diseases through its proprietary Affinia Rationally-designed Therapies (ART) platform. This platform aims to overcome key challenges related to efficacy, safety, and production costs traditionally associated with gene therapies. Affinia Therapeutics is committed to having a significant positive impact on the lives of patients globally and fosters a culture rooted in integrity, passion, and teamwork. Employees work in a fast-paced, dynamic environment alongside an experienced management team with a strong industry track record. The company values innovation and collaboration, providing an opportunity for employees to contribute meaningfully to the advancement of therapeutic solutions.